These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1994 related items for PubMed ID: 17374834

  • 1. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP, Kramer GW, Van Schil PE, Legrand C, Smit EF, Schramel F, Tjan-Heijnen VC, Biesma B, Debruyne C, van Zandwijk N, Splinter TA, Giaccone G, European Organisation for Research and Treatment of Cancer-Lung Cancer Group.
    J Natl Cancer Inst; 2007 Mar 21; 99(6):442-50. PubMed ID: 17374834
    [Abstract] [Full Text] [Related]

  • 2. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P, Herndon J, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.
    Cancer; 1996 Jun 01; 77(11):2393-9. PubMed ID: 8635112
    [Abstract] [Full Text] [Related]

  • 3. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.
    Ann Thorac Surg; 2004 Oct 01; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [Abstract] [Full Text] [Related]

  • 4. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K, Tsuchiya R, Mori T, Tada H, Ichinose Y, Koike T, Kato H, Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group.
    J Thorac Cardiovasc Surg; 2003 Feb 01; 125(2):254-60. PubMed ID: 12579093
    [Abstract] [Full Text] [Related]

  • 5. Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.
    Rice TW, Adelstein DJ, Koka A, Tefft M, Kirby TJ, Van Kirk MA, Taylor ME, Olencki TE, Peereboom D, Budd GT.
    Ann Thorac Surg; 1995 Sep 01; 60(3):586-91; discussion 591-2. PubMed ID: 7677484
    [Abstract] [Full Text] [Related]

  • 6. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group.
    Huber RM, Flentje M, Schmidt M, Pöllinger B, Gosse H, Willner J, Ulm K, Bronchial Carcinoma Therapy Group.
    J Clin Oncol; 2006 Sep 20; 24(27):4397-404. PubMed ID: 16983107
    [Abstract] [Full Text] [Related]

  • 7. Which patients should be operated on after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7-year experience in 175 patients.
    Stefani A, Alifano M, Bobbio A, Grigoroiu M, Jouni R, Magdeleinat P, Regnard JF.
    J Thorac Cardiovasc Surg; 2010 Aug 20; 140(2):356-63. PubMed ID: 20381815
    [Abstract] [Full Text] [Related]

  • 8. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H, De Leyn P, Vansteenkiste J, Dooms C, Van Raemdonck D, Nafteux P, Coosemans W, Lerut T.
    Eur J Cardiothorac Surg; 2009 Sep 20; 36(3):433-9. PubMed ID: 19502079
    [Abstract] [Full Text] [Related]

  • 9. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N, Santelmo N, Naafa N, Serre A, Hilgers W, Mineur L, Molinari N, Reboul F.
    Eur J Cardiothorac Surg; 2008 May 20; 33(5):829-36. PubMed ID: 18367406
    [Abstract] [Full Text] [Related]

  • 10. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.
    Keller SM, Adak S, Wagner H, Herskovic A, Komaki R, Brooks BJ, Perry MC, Livingston RB, Johnson DH.
    N Engl J Med; 2000 Oct 26; 343(17):1217-22. PubMed ID: 11071672
    [Abstract] [Full Text] [Related]

  • 11. Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935.
    Jaklitsch MT, Herndon JE, DeCamp MM, Richards WG, Kumar P, Krasna MJ, Green MR, Sugarbaker DJ.
    J Surg Oncol; 2006 Dec 01; 94(7):599-606. PubMed ID: 17039491
    [Abstract] [Full Text] [Related]

  • 12. Induction chemoradiation therapy followed by surgical resection for non-small cell lung cancer (NSCLC) invading the thoracic inlet.
    Fischer S, Darling G, Pierre AF, Sun A, Leighl N, Waddell TK, Keshavjee S, de Perrot M.
    Eur J Cardiothorac Surg; 2008 Jun 01; 33(6):1129-34. PubMed ID: 18407511
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel/Platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer.
    Choi IS, Oh DY, Kwon JH, Kim SI, Park SR, Bak JY, Kim JH, Kim DW, Kim YT, Kim TY, You CK, Kim YW, Heo DS, Bang YJ, Sung SW, Park CI, Kim NK.
    Jpn J Clin Oncol; 2005 Jan 01; 35(1):6-12. PubMed ID: 15681597
    [Abstract] [Full Text] [Related]

  • 14. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
    Pezzetta E, Stupp R, Zouhair A, Guillou L, Taffé P, von Briel C, Krueger T, Ris HB.
    Eur J Cardiothorac Surg; 2005 Jun 01; 27(6):1092-8. PubMed ID: 15896624
    [Abstract] [Full Text] [Related]

  • 15. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160).
    Rusch VW, Giroux DJ, Kraut MJ, Crowley J, Hazuka M, Winton T, Johnson DH, Shulman L, Shepherd F, Deschamps C, Livingston RB, Gandara D.
    J Clin Oncol; 2007 Jan 20; 25(3):313-8. PubMed ID: 17235046
    [Abstract] [Full Text] [Related]

  • 16. Induction chemotherapy with and without recombinant human granulocyte colony-stimulating factor support in locally advanced stage IIIA/B non-small cell lung cancer.
    Fischer JR, Manegold C, Bülzebruck H, Vogt-Moykopf I, Drings P.
    Semin Oncol; 1994 Jun 20; 21(3 Suppl 4):20-7. PubMed ID: 7516094
    [Abstract] [Full Text] [Related]

  • 17. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
    Rusu P, Ciuleanu TE, Cernea D, Pelau D, Gaal V, Cebotaru C, Guttman T, Todor N, Ghilezan N.
    J BUON; 2007 Jun 20; 12(1):33-9. PubMed ID: 17436399
    [Abstract] [Full Text] [Related]

  • 18. Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy.
    Bischof M, Debus J, Herfarth K, Muley T, Kappes J, Storz K, Hoffmann H.
    Strahlenther Onkol; 2007 Dec 20; 183(12):679-84. PubMed ID: 18040612
    [Abstract] [Full Text] [Related]

  • 19. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
    Bradley JD, Paulus R, Graham MV, Ettinger DS, Johnstone DW, Pilepich MV, Machtay M, Komaki R, Atkins J, Curran WJ, Radiation Therapy Oncology Group.
    J Clin Oncol; 2005 May 20; 23(15):3480-7. PubMed ID: 15908657
    [Abstract] [Full Text] [Related]

  • 20. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
    Caglar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, Jänne PA, Johnson BE, Allen AM.
    Cancer; 2009 Sep 15; 115(18):4156-66. PubMed ID: 19551884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 100.